Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ashley J. Birkett"'
Autor:
Barnabas G. Williams, Lloyd D. W. King, David Pulido, Doris Quinkert, Amelia M. Lias, Sarah E. Silk, Robert J. Ragotte, Hannah Davies, Jordan R. Barrett, Kirsty McHugh, Cassandra A. Rigby, Daniel G. W. Alanine, Lea Barfod, Michael W. Shea, Li An Cowley, Rebecca A. Dabbs, David J. Pattinson, Alexander D. Douglas, Oliver R. Lyth, Joseph J. Illingworth, Jing Jin, Cecilia Carnrot, Vinayaka Kotraiah, Jayne M. Christen, Amy R. Noe, Randall S. MacGill, C. Richter King, Ashley J. Birkett, Lorraine A. Soisson, Katherine Skinner, Kazutoyo Miura, Carole A. Long, Matthew K. Higgins, Simon J. Draper
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) and RH5-interacting protein (RIPR) to form an essential heterotrimeri
Externí odkaz:
https://doaj.org/article/c0357f954cd04ff984155d03439a386e
Autor:
Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, Pongphaya Pongsuwan, Kesinee Chotivanich, Joel Tarning, Richard M. Hoglund, Markus Winterberg, Mavuto Mukaka, Pimnara Peerawaranun, Pasathorn Sirithiranont, Zoe Doran, Christian F. Ockenhouse, Karen Ivinson, Cynthia Lee, Ashley J. Birkett, David C. Kaslow, Pratap Singhasivanon, Nicholas P.J. Day, Arjen M. Dondorp, Nicholas J. White, Sasithon Pukrittayakamee
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 1, Pp 33-41 (2020)
Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass
Externí odkaz:
https://doaj.org/article/10658784ace14906a79c8aa180809379
Autor:
Saskia C van der Boor, Merel J Smit, Stijn W van Beek, Jordache Ramjith, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Peter Pickkers, Yimin Wu, Emily Locke, Shwu-Maan Lee, John Aponte, C Richter King, Ashley J Birkett, Kazutoyo Miura, Morolayo A Ayorinde, Robert W Sauerwein, Rob ter Heine, Christian F Ockenhouse, Teun Bousema, Matthijs M Jore, Matthew B B McCall
Publikováno v:
Lancet Infectious Diseases, 22, 1596-1605
Lancet Infectious Diseases, 22, 11, pp. 1596-1605
Lancet Infectious Diseases, 22, 11, pp. 1596-1605
Contains fulltext : 287660.pdf (Publisher’s version ) (Open Access) BACKGROUND: Malaria elimination requires interruption of the highly efficient transmission of Plasmodium parasites by mosquitoes. TB31F is a humanised monoclonal antibody that bind
Autor:
Saskia C. van der Boor, Merel Smit, Stijn W. van Beek, Jordache Ramjith, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Peter Pickkers, Yimin Wu, Emily Locke, Shwu-Maan Lee, C. Richter King, Ashley J. Birkett, Kazutoyo Miura, Morolayo A. Ayorinde, Robert W. Sauerwein, Rob ter Heine, Christian F. Ockenhouse, Teun Bousema, Matthijs M. Jore, Matthew McCall
Publikováno v:
SSRN Electronic Journal.
Autor:
Cynthia Lee, Amanda Fabra-García, Perry J.J. van Genderen, Ashley J. Birkett, António M. Mendes, Helena Nunes-Cabaço, Yimin Wu, Miguel Prudêncio, Sake J. de Vlas, Wouter Graumans, Gerdie M. de Jong, Isaie J. Reuling, Christian F. Ockenhouse, Rob Koelewijn, Geert-Jan van Gemert, Robert W. Sauerwein, Annie S. P. Yang, Luc E. Coffeng, Jaap J. van Hellemond
Publikováno v:
Science Translational Medicine, 12, 544
Science Translational Medicine, 12
Science Translational Medicine, 12(544):eaay2578. American Association for the Advancement of Science
Science Translational Medicine, 12
Science Translational Medicine, 12(544):eaay2578. American Association for the Advancement of Science
For some diseases, successful vaccines have been developed using a nonpathogenic counterpart of the causative microorganism of choice. The nonpathogenicity of the rodent Plasmodium berghei (Pb) parasite in humans prompted us to evaluate its potential
Autor:
Wei Chan, Ashley J. Birkett, Gang Yin, Alexander Steiner, Neeraj Kapoor, Cuong D. Tran, Aaron K. Sato, Ivana Vanjak, Aym Berges, Kazutoyo Miura, Jeff Fairman, Carole A. Long, Thao P. Pham, James Rozzelle
Publikováno v:
Biochemistry
Malaria, one of the most common vector borne human diseases, is a major world health issue. In 2015 alone, more than 200 million people were infected with malaria, out of which, 429 000 died. Even though artemisinin-based combination therapies (ACT)
Autor:
Isaie J, Reuling, António M, Mendes, Gerdie M, de Jong, Amanda, Fabra-García, Helena, Nunes-Cabaço, Geert-Jan, van Gemert, Wouter, Graumans, Luc E, Coffeng, Sake J, de Vlas, Annie S P, Yang, Cynthia, Lee, Yimin, Wu, Ashley J, Birkett, Christian F, Ockenhouse, Rob, Koelewijn, Jaap J, van Hellemond, Perry J J, van Genderen, Robert W, Sauerwein, Miguel, Prudêncio
Publikováno v:
Science translational medicine. 12(544)
For some diseases, successful vaccines have been developed using a nonpathogenic counterpart of the causative microorganism of choice. The nonpathogenicity of the rodent
Autor:
Amit Singh, Kavita Singh, Dhiraj Hans, Jaya Patel, K. Anil, Swarnendu Kaviraj, Ajay Srinivasan, Chetan E. Chitnis, Geetanjali Uppal, Gaurav Pandey, Santosh Gangireddy, Ashley J. Birkett, Rukmini Bhardwaj, Darrick Carter, David C. Kaslow, Virander S. Chauhan, Ankita Rawat, Sanjay Singh, Ankita Singh, Paushali Mukherjee, Rajeshwar Rao, Rudrappa Patil, R.L. Madhusudhan, Ahmad Rushdi Shakri, Syed Shams Yazdani, Meenakshi Bakshi, Steve Reed, Purnima Kumar, Rajender Jena, Shantanu Mehta
Publikováno v:
npj Vaccines, Vol 3, Iss 1, Pp 1-10 (2018)
NPJ Vaccines
NPJ Vaccines
Reticulocyte invasion by Plasmodium vivax requires interaction of the Duffy-binding protein (PvDBP) with host Duffy antigen receptor for chemokines (DARCs). The binding domain of PvDBP maps to a cysteine-rich region referred to as region II (PvDBPII)
Autor:
April K. Kathcart, C. K. Lee, Daniel Emerling, R. Weltzin, Aziz N. Qabar, Wayne Volkmuth, Kevin Hauns, Silas A. Davidson, Charles Magee, Erik Jongert, Jack Komisar, Susan Cicatelli, Johan Vekemans, Ulrike Wille-Reece, Norman C. Waters, Adrian T. Kress, Danielle Morelle, Jason W. Bennett, Marc Lievens, Matthew E. Griffith, Joe Cohen, Jason A. Regules, Paige E. Waterman, Jeffrey R. Livezey, Robert Paris, Ashley J. Birkett, Christian F. Ockenhouse, Sheetij Dutta, Bebi Yassin-Rajkumar, James E. Moon, W. Ripley Ballou, Mariusz Wojnarski, David C. Kaslow, Kristopher M. Paolino, Patrick S. Twomey, William H. Robinson
Publikováno v:
Journal of Infectious Diseases. 214:762-771
BACKGROUND Three full doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria parasite infection (CHMI) and natural exposure. Immunization regimens, including a delayed fractional third dose, were assessed for
Remarkable progress has been made in coordinated malaria control efforts with substantial reductions in malaria-associated deaths and morbidity achieved through mass administration of drugs and vector control measures including distribution of long-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b8bd90d91eb5da2a380e16edda7691
https://europepmc.org/articles/PMC5580511/
https://europepmc.org/articles/PMC5580511/